Genome Editing: Promoting Responsible Research

Pharmaceut Med. 2019 Jun;33(3):187-191. doi: 10.1007/s40290-019-00276-1.

Abstract

For more than 40 years, scientists have been developing tools and technologies for genome modification; however, initial progress was slow and few outside of the molecular biology community took an interest in the field. Everything has dramatically changed with the recent appearance of the so-called precision approaches, and especially with the 'CRISPR (Clustered Regularly Interspaced Short Palindromic Repeat) revolution'. With great powers come great responsibilities. CRISPR-derived technologies have been proven efficient, cheap, rather easy and fast, and provided universal access to genome modification techniques beyond the leading research centers and reference laboratories. The popularization of techniques to manipulate the human genome and that of all other living beings consequently raises many essential questions, on the ethical and legal sides, both for the scientific community and the lay public. In order to mitigate excessive hype and concern among citizens, a call for the mobilization of the various stakeholders is now urgent through a global governance of genome editing.

MeSH terms

  • Animals
  • CRISPR-Cas Systems
  • Ethics, Research
  • Gene Editing / ethics*
  • Gene Editing / legislation & jurisprudence*
  • Genome, Human
  • Humans